Condition
Neurofibromatosis Type 1 (NF1) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Neurofibromatosis Type 1 (NF1) clinical trials that are recruiting, at sites in 4 countries (most in China (1), Australia (1), South Korea (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 4Countries
All recruiting trials (2)
-
Real-world use of selumetinib for adult NF1 with inoperable plexiform neurofibromas
This registry-following study tests how well and safely selumetinib works in adults with NF1 who have symptomatic, inoperable PN.
-
Testing PAS-004 for adults with Neurofibromatosis Type 1 and plexiform neurofibromas
This study is testing a new medication called PAS-004 to see if it is safe and helps adults with Neurofibromatosis Type 1 and painful plexiform neurofibromas.
Related topics
Quick answers
How many Neurofibromatosis Type 1 (NF1) clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (1 trial), Australia (1 trial), South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.